Search Within

Survivorship Research

Formats
  1. Journal Article (9001)
  2. Meeting Abstract (5248)
  3. Book Section (579)
  4. Review (366)
  5. Editorial (234)
  6. Research Letter (138)
  7. Conference Paper (104)
  8. Correspondence (92)
  9. Guidelines (90)
  10. Miscellaneous (78)
  11. Book Whole (30)
Groups
  1. Department of Medicine (9323)
  2. Population Sciences Research Program (5752)
  3. Solid Tumor Oncology Division (5243)
  4. Surgery (5197)
  5. Epidemiology and Biostatistics (3665)
  6. Division of Subspecialty Medicine (3268)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (792)
  3. Michael Zelefsky (755)
  4. Sergio Giralt (702)
  5. Mark Robson (682)
  6. Joachim Yahalom (634)

More People

Years
  1. 2025 (380)
  2. 2024 (844)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (933)

More Years

Publications
  1. Journal of Clinical Oncology (1892)
  2. International Journal of Radiation Oncology, Biology, Physics (912)
  3. Blood (723)
  4. Annals of Surgical Oncology (602)
  5. Cancer (334)
  6. Cancer Research (333)

More Publications

Publishers
  1. Elsevier Inc. (2394)
  2. American Society of Clinical Oncology (2041)
  3. Springer (1558)
  4. Wiley Blackwell (816)
  5. Oxford University Press (792)
  6. American Society of Hematology (790)

More Publishers

Results (15960)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
    Journal Article

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Palomba, M. L.; Noy, A.; Caron, P.; Hamlin, P.; Kumar, A.; Matasar, M.; Owens, C.; more...
    Blood Neoplasia (2024)

    Fulltext@MSK | Save
  • Retinoblastoma: Metastatic disease
    Book Section

    Dunkel, I. J.; Chantada, G. L.
    In Berry, J. L.; Damato, B. E.; Singh, A. D. (Eds.) Clinical Ophthalmic Oncology: Retinoblastoma. 4th ed (2024)

    Fulltext@MSK | Save
  • Interference with activities of daily living according to pain level after breast surgery
    Journal Article

    Pawloski, K. R.; Hnin, S.; Kalvin, H. L.; Sevilimedu, V.; Le, T.; Tadros, A. B.; Kirstein, L. J.; Morrow, M.; Moo, T. A.
    Surgical Oncology Insight (2024)

    Fulltext@MSK | Save
  • Clinical challenges in breast care for patients with PTEN pathogenic variants: A case series and literature review
    Journal Article

    Williams, A. D.; LaRoy, J.; Le, T.; Mangino, D. A.; Robson, M. E.; Heerdt, A. S.; Moo, T. A.
    Surgical Oncology Insight (2024)

    Fulltext@MSK | Save
  • CTEP 10590, NORM: Nodular lymphocyte predominant Hodgkin lymphoma patients treated in a randomized phase II trial with either rituximab or mosunetuzumab
    Meeting Abstract

    Steiner, R.; Bock, A. M.; Herrera, A. F.; Zulfa, O.; Hoffmann, M.; Ibrahimi, S.; Galanina, N.; Lee, H. J.; Green, M.; Lin, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A phase III, randomized study of daratumumab, cyclophosphamide, bortezomib and dexamethasone (DARA-VCD) induction followed by autologous stem cell transplant or Dara-VCD consolidation and daratumumab maintenance in patients with newly diagnosed AL amyloidosis
    Meeting Abstract

    Hagen, P.; Sidana, S.; Parker, T. L.; Walker, B. A.; Sanchorawala, V.; Zonder, J. A.; Kourelis, T.; D'Souza, A.; Landau, H. J.; Rosenthal, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Bridging radiotherapy may decrease inflammation prior to CAR-T cell therapy
    Meeting Abstract

    Patel, R. R.; Tward, A.; Fregonese, B.; Hubbeling, H.; Lapen, K.; Mankuzhy, N. P.; Raj, S. S.; Perales, M. A.; Shouval, R.; Yahalom, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Belantamab mafodotin, nirogacestat and pomalidomide for patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Hassoun, H.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; Hashmi, H.; Maclachlan, K. H.; Rajeeve, S.; Shah, U. A.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save